Dieter Bosshardt
Zero peri-implantitis – the prevention concept in implant dentistry
- Swiss dental researcher and Associate Professor at the University of Bern’s School of Dental Medicine.
- He directs the Robert K. Schenk Laboratory of Oral Histology and lectures in the departments of Periodontology, Prosthodontics, and Oral Surgery.
- He holds a Master’s and PhD in Natural Sciences from ETH Zurich, completed a postdoctoral fellowship at the University of Montreal, and earned his habilitation in Oral Structural and Developmental Biology from the University of Bern.
- Prof. Bosshardt’s research focuses on cementogenesis, periodontal and bone regeneration, and healing processes around dental implants and biomaterials.
- He has authored over 220 scientific publications and is an active member of several professional organizations, including IADR, ITI, and ORA.
- In 2024, he received the IADR/PRG Award in Regenerative Periodontal Medicine, recognizing his significant contributions to the field.
Nationality: Switzerland
Scientific areas: Dental Industry Forum (Patent)
7 of november, from 14h30 until 19h00
Dental Industry Forum
Conference summary
Soft tissue bond – the missing element for a dynamic peri-implant defense barrier
For the first time, a biochemical bond between the peri-implant soft-tissue and a transmucosal synthetic element was histologically observed and scientifically documented. This newly discovered soft-tissue bond plays a critical role in maintaining long-term peri-implant health by creating a dynamic defense against downward migration of plaque, inflammation and disease progression.
Early soft-tissue healing – the foundation for predictable long-term esthetics
Immediate soft-tissue behavior during early healing is a key determinant of long-term esthetic outcomes. The soft-tissue response around synthetic implant, abutment or crown characteristics impacts short-, mid- and long-term treatment outcomes. Hence, the foundation for long-lasting esthetic results is laid at the time of implant placement.
What is the best alternative: “Tissue level” or “bone level” implants? Results after 36 years of clinical implantology
Since the establishment of the concept of osseointegration, the use of endosseous implants has continued to grow. The first evidence of lost implants is attributed to the Mayan civilization around 600 AD. During this period, many attempts to replace missing teeth were made, using a wide range of materials and very different techniques to keep them in place.
After a slow start, dental implants began to be used in patients with increasing frequency. Indications developed as implants were perfected in terms of their shapes, designs, surface treatments and connections.
Over time, mechanical and biological problems began to emerge. Mechanical failures led to further developments in implant design. Biological problems took longer to be understood and for approaches to treating these new pathologies to emerge. Inflammations of soft and hard tissues adjacent to implants were diagnosed and treatment protocols were developed.
The annual global dental implant market has grown enormously, with an estimated 12 to 18 million implants sold, while in Europe alone the annual market is estimated at around 5.5 to 6 million implants.
According to statistics from the American Dental Association, 5 million implants are placed annually in the USA alone. Given that peri-implant mucositis and peri-implantitis are highly prevalent and their treatment is challenging, unpredictable and associated with significant morbidity, these results will lead to a rate of 2.64 to 4 million cases of peri-implantitis worldwide.
See the other speakers at the Industry Forum.
Bronze Sponsor
